The 1827.HK stock closed at HK$0.71, down 24.47% from the prior close on the HKSE in Hong Kong, making Miricor one of the top losers today. The drop followed a one-day fall of HK$0.23 and left the share price near the year low of HK$0.60. Trading volume was reported as 0 on the latest quote while average volume sits at 5,964 shares, highlighting thin liquidity. We examine drivers, valuation, technical levels and what the Meyka AI forecast implies for near-term trading.
Price action and drivers for 1827.HK stock
Miricor Enterprises (1827.HK) moved from a previous close of HK$0.94 to HK$0.71, a one-day change of -24.47%. The intraday range was flat at HK$0.71 as the quote shows day low and day high both HK$0.71, indicating a single priced trade or thin order book. Market capitalisation stands at HK$280,000,000 with 400,000,000 shares outstanding, and investors cited weak sector flows in Hong Kong consumer cyclical names as an additional pressure point.
Fundamentals and valuation for 1827.HK stock
On fundamentals Miricor reports EPS HK$0.03 and a quoted PE of 23.33, versus a trailing PE of 16.96 in certain ratios, reflecting mixed reported metrics. Key ratios show price to sales 0.69, price to book 1.90, and free cash flow yield 33.73%, indicating solid cash conversion. The company operates three CosMax+ centres in Hong Kong and carries net cash metrics with enterprise value HK$186,442,000 and debt to equity 0.60.
Technicals, liquidity and sector context for 1827.HK stock
Technicals show RSI 42.57, ADX 38.40 suggesting a strong trend, and Bollinger bands at 0.60–0.94. Average 50-day price is HK$0.83 and 200-day average is HK$0.98, both above the close, signalling short-term weakness. The Consumer Cyclical sector in Hong Kong is down and its average PE is 20.72, so Miricor’s relative underperformance adds to selling pressure. Low average daily volume (5,964) means price moves can amplify on sparse flow.
Meyka AI rates 1827.HK with a score out of 100 and valuation view
Meyka AI rates 1827.HK with a score out of 100: 63.35 (Grade B, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst inputs. The company rating dated 2026-03-17 notes DCF strength but flags PE and PB as relative weaknesses. Analysts should treat this grade as model-based information and not personalised advice.
Meyka AI forecast, price targets and downside scenarios for 1827.HK stock
Meyka AI’s forecast model projects monthly HK$0.85, quarterly HK$0.66, and yearly HK$0.90. Versus the current HK$0.71, the yearly projection implies an upside of 26.76% while the quarterly number implies a short-term downside of -7.04%. These targets assume stable clinic demand and no material capital actions; forecasts are model-based projections and not guarantees.
Risks, catalysts and trading strategy for 1827.HK stock
Primary risks include low liquidity, concentrated Hong Kong exposure and sensitivity to consumer discretionary spending. Catalysts that could stabilise the stock are stronger foot traffic at CosMax+ centres, better-than-expected earnings or a recovery in sector flows. Given the thin average volume and volatile price moves, a cautious trading approach, tight size limits and stop placement are prudent for short-term traders.
Final Thoughts
Miricor (1827.HK) closed the session at HK$0.71, down 24.47%, marking it among the top losers on the HKSE in Hong Kong today. Fundamentals show modest profitability with EPS HK$0.03 and mixed valuation: PE around 23.33 on the quote and stronger cash metrics including free cash flow yield 33.73%. Meyka AI rates the stock 63.35/100 (Grade B, HOLD) and projects a yearly target of HK$0.90, implying 26.76% upside from the current price, while a quarterly projection of HK$0.66 flags short-term downside risk of -7.04%. Traders should weigh low liquidity and sector headwinds against resilient cash flow metrics. These figures are model outputs and not guarantees; use them with position sizing and risk controls.
FAQs
Why did 1827.HK stock fall so sharply today?
The sharp drop to HK$0.71 reflects thin liquidity, sector weakness in Consumer Cyclical names and short-term selling pressure. No single public corporate event explains the full move, so market flows and low average volume likely amplified the decline.
What valuation metrics matter for 1827.HK stock?
Key metrics include EPS HK$0.03, quoted PE 23.33, price to sales 0.69, price to book 1.90, and strong free cash flow yield 33.73%. These suggest mixed valuation: modest earnings but solid cash conversion.
What does Meyka AI forecast imply for 1827.HK stock?
Meyka AI’s model projects yearly HK$0.90, implying 26.76% upside from HK$0.71, and quarterly HK$0.66 implying short-term downside. Forecasts are model-based projections and not guarantees.
Is 1827.HK stock a buy after the drop?
Meyka AI gives a Grade B and Suggestion HOLD. Investors should assess liquidity, clinic performance and their risk tolerance before buying. Use small position sizes and clear stop-loss rules.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)